CN103830659A - Traditional Chinese medicine for treating leucoderma - Google Patents
Traditional Chinese medicine for treating leucoderma Download PDFInfo
- Publication number
- CN103830659A CN103830659A CN201210492582.0A CN201210492582A CN103830659A CN 103830659 A CN103830659 A CN 103830659A CN 201210492582 A CN201210492582 A CN 201210492582A CN 103830659 A CN103830659 A CN 103830659A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 241000190633 Cordyceps Species 0.000 claims abstract description 19
- 241000628997 Flos Species 0.000 claims description 33
- 210000000582 semen Anatomy 0.000 claims description 33
- 150000007965 phenolic acids Chemical class 0.000 claims description 16
- 241000407170 Curcuma Species 0.000 claims description 9
- 235000014375 Curcuma Nutrition 0.000 claims description 9
- 241001446509 Psoralea Species 0.000 claims description 9
- 241000207929 Scutellaria Species 0.000 claims description 9
- 241000698291 Rugosa Species 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 24
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 11
- 244000068988 Glycine max Species 0.000 abstract description 6
- 235000010469 Glycine max Nutrition 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 2
- 244000164480 Curcuma aromatica Species 0.000 abstract 2
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 2
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229930183842 salvianolic acid Natural products 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 19
- 206010047642 Vitiligo Diseases 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 10
- 231100000957 no side effect Toxicity 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000049 pigment Substances 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241001107116 Castanospermum australe Species 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating leucoderma. The traditional Chinese medicine comprises the following medicaments in parts by weight: 20-30 parts of angelica sinensis, 20-30 parts of scutellaria baicalensis, 50-60 parts of fructus psoraleae, 10-20 parts of black soybean, 10-20 parts of black date, 10-20 parts of curcuma aromatica, 6-10 parts of carthamus tinctorius, 6-10 parts of peach kernel, 5-15 parts of cordyceps flower, 1-5 parts rose as well as 30-40 parts of effective parts salvianolic acids. The angelica sinensis, scutellaria baicalensis and fructus psoraleae in the medicaments of the traditional Chinese medicine for treating leucoderma all are beneficial for invigorating qi and blood and tonifying the liver and kidney, the black soybean and the black date can promote qi to activate blood, other medicaments such as curcuma aromatica and carthamus tinctorius can dispell wind and remove obstruction in the meridians and promote qi to activate blood, and are all best medicaments for treating leucoderma. The medicine is small in significant component amount and is applicable to mass consumption level, and various effective components in the medicaments can be absorbed by human bodies, are beneficial for enhancing human body constitution, are high in curative effect and free of side effect.
Description
Technical field
The present invention relates to the dermopathic field of Chinese medicines, relate to specifically one and treat leukodermic Chinese medicine.
Background technology
Vitiligo is a kind of common multiple pigmented dermatosis, this disease forms white macula as feature taking local or general property depigmentation, a kind of acquired, the de-white patch forming that loses of skin pigment, can betide any age, causing the direct cause of disease of vitiligo morbidity is disappearance and the dysfunction of melanocyte, and melanocyte disappearance reduces nature can reduce melanic synthetic quantity, thereby just can cause the destruction of melanocyte is made to its minimizing as dysimmunity; Dysfunction mainly refers to that the situation of being obstructed has appearred in melanocyte in the process of synthesis of melanin, the leukodermic indirect cause of disease is mainly to have comprised Nervous and Mental Factors, wound factor, chemical factor, endocrine factors, role of autoimmune factors, copper ion disappearance factor, the large class of environmental factors etc. nine, vitiligo is that world's dermatosis is distributed one of pertinacious disease, is generally to adopt Chinese medicine to take or make skin graft at present, even in methods such as ultraviolet therapys for leukodermic treatment, but still can not reach good therapeutic effect, and medical expense is high.
Summary of the invention
In order to address the above problem, to the invention provides a kind of good effect, cure the leukodermic Chinese medicine for the treatment of fast, economical and practical and that have no side effect.
In order to achieve the above object, the present invention is achieved by the following technical solutions:
The present invention is that one is treated leukodermic Chinese medicine, this Chinese medicine comprises the medicine of following weight portion: Radix Angelicae Sinensis 20-30 part, Radix Scutellariae 20-30 part, Fructus Psoraleae 50-60 part, Semen sojae atricolor 10-20 part, Fructus Jujubae 10-20 part, Radix Curcumae 10-20 part, Flos Carthami 6-10 part, Semen Persicae 6-10 part, Cordyceps 5-15 part, Flos Rosae Rugosae 1-5 part, this medicine also comprises poly phenolic acid of Radix Salviae Miltiorrhizae effective site 30-40 part.
The leukodermic Chinese medicine for the treatment of of the present invention, this Chinese medicine comprises the medicine of following weight portion: 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Scutellariaes, 50 parts of Fructus Psoraleaes, 10 parts, Semen sojae atricolor, 10 parts of Fructus Jujubaes, 10 parts of Radix Curcumaes, 6 parts, Flos Carthami, 6 parts, Semen Persicae, 5 parts of Cordyceps, 1 part of Flos Rosae Rugosae, this medicine also comprises 30 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
The leukodermic Chinese medicine for the treatment of of the present invention, this Chinese medicine comprises the medicine of following weight portion: 25 parts of Radix Angelicae Sinensis, 25 parts of Radix Scutellariaes, 55 parts of Fructus Psoraleaes, 15 parts, Semen sojae atricolor, 15 parts of Fructus Jujubaes, 15 parts of Radix Curcumaes, 8 parts, Flos Carthami, 8 parts, Semen Persicae, 10 parts of Cordyceps, 3 parts of Flos Rosae Rugosaes, this medicine also comprises 35 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
The leukodermic Chinese medicine for the treatment of of the present invention, this Chinese medicine comprises the medicine of following weight portion: 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Scutellariaes, 60 parts of Fructus Psoraleaes, 20 parts, Semen sojae atricolor, 20 parts of Fructus Jujubaes, 20 parts of Radix Curcumaes, 10 parts, Flos Carthami, 10 parts, Semen Persicae, 15 parts of Cordyceps, 5 parts of Flos Rosae Rugosaes, this medicine also comprises 40 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
The invention has the beneficial effects as follows:
Radix Angelicae Sinensis sweet in the mouth, pungent, bitter, warm in nature, the effect that having enriches blood invigorates blood circulation, Radix Angelicae Sinensis can also regulate the immunologic function of body simultaneously, has effect anticancer, antibacterial, arteriosclerosis, and benefiting vital QI and blood, tonification liver have good effect to treatment vitiligo; Radix Scutellariae bitter in the mouth, cold, has effect of heat clearing and damp drying, blood pressure lowering, removing toxic substances, can liver and kidney tonifying; Fructus Psoraleae has effect of reinforcing the kidney and supporting YANG, helping inspiration to relieve asthma, main insufficiency of kidney-YANG, and failure of the kidney in receiving QI, asthenia of both the spleen and kidney is mainly used for treating vitiligo; Nutritious black bean is abundant, contain the multiple nutritional components such as protein, fat, vitamin, trace element, there is again various bioactivators simultaneously, as studies on black soybean pigment, Semen sojae atricolor polysaccharide and isoflavone etc., especially studies on black soybean pigment is a kind of active components of plants with important medical value, and treatment vitiligo is had to good curative effect; Fructus Jujubae moistens cardiopulmonary, promoting the production of body fluid to quench thirst, and aging resistance, can drive qi-blood circulating, reduces cardiovascular silting up; Radix Curcumae nature and flavor with return through: pungent, bitter, cold, return liver, the heart, lung meridian, major function is promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice etc., regulate vim and vigour; Semen Persicae bitter but sweet flavor and property are flat, can enter the heart, liver, large intestine, and blood circulation promoting and blood stasis dispelling effect is very wide, availablely control the various worn-out diseases of stagnation of blood stasis; Flos Carthami has effect of promoting blood flow to regulate menstruation, eliminating stasis to stop pain, and Semen Persicae Flos Carthami is all the medicine of blood circulation promoting and blood stasis dispelling, and both are used in conjunction with effectively promoting flow of QI and blood, and treatment vitiligo is all had to good effect; The profile of Cordyceps is similar to Cordyceps, and Cordyceps contains cordycepin, aminoacid, polysaccharide, protein etc., is that nutritional labeling is very abundant, meanwhile, also finds that Cordyceps has effect of liver and kidney tonifying, tonifying the lung spleen invigorating, can effectively improve the function of human body; Flos Rosae Rugosae sweet in the mouth, micro-hardship, temperature, main effect is circulation of qi promoting, has resolving depression, and blood, effect of pain relieving.
Poly phenolic acid of Radix Salviae Miltiorrhizae sterilization, activating blood circulation to dissipate blood stasis, improve microcirculation, remove the effect such as free radical, poly phenolic acid of Radix Salviae Miltiorrhizae and Semen Persicae, Flos Carthami all can play the effect of mutually promoting, and can effectively improve the situation of patients with vitiligo.
The present invention treats the Radix Angelicae Sinensis, Radix Scutellariae and the Fructus Psoraleae that in the medicine of leukodermic Chinese medicine, contain is all of value to benefiting vital QI and blood, liver and kidney tonifying, Semen sojae atricolor and Fructus Jujubae energy promoting flow of QI and blood, the other drugs such as Radix Curcumae Flos Carthami are energy dispelling wind and removing obstruction in the collateral, promoting flow of QI and blood all, are all the leukodermic optimal drugs for the treatment of, this important component is low, is applicable to level of mass consumption, the various effective ingredient that contain in medicine can be absorbed by the body, be conducive to strengthen human body constitution, therapeutic effect is high, has no side effect.
Detailed description of the invention
In order to deepen the understanding of the present invention, below in conjunction with embodiment, the present invention is described in further detail, this embodiment, only for explaining the present invention, does not form and limits protection scope of the present invention.
The present invention is that one is treated leukodermic Chinese medicine, and described Chinese medicine comprises the medicine of following weight portion: Radix Angelicae Sinensis 20-30 part, Radix Scutellariae 20-30 part, Fructus Psoraleae 50-60 part, Semen sojae atricolor 10-20 part, Fructus Jujubae 10-20 part, Radix Curcumae 10-20 part, Flos Carthami 6-10 part, Semen Persicae 6-10 part, Cordyceps 5-15 part, Flos Rosae Rugosae 1-5 part, this medicine also comprises poly phenolic acid of Radix Salviae Miltiorrhizae effective site 30-40 part, and this medicine can effectively be treated leukodermic symptom, has no side effect.
One of the present invention is treated leukodermic Chinese medicine, and described Chinese medicine comprises the medicine of following weight portion: 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Scutellariaes, 50 parts of Fructus Psoraleaes, 10 parts, Semen sojae atricolor, 10 parts of Fructus Jujubaes, 10 parts of Radix Curcumaes, 6 parts, Flos Carthami, 6 parts, Semen Persicae, 5 parts of Cordyceps, 1 part of Flos Rosae Rugosae, this medicine also comprises 30 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites, this medicine can effectively be treated leukodermic symptom, have no side effect, therapeutic effect is good.
The present invention is that one is treated leukodermic Chinese medicine, and described Chinese medicine comprises the medicine of following weight portion: 25 parts of Radix Angelicae Sinensis, 25 parts of Radix Scutellariaes, 55 parts of Fructus Psoraleaes, 15 parts, Semen sojae atricolor, 15 parts of Fructus Jujubaes, 15 parts of Radix Curcumaes, 8 parts, Flos Carthami, 8 parts, Semen Persicae, 10 parts of Cordyceps, 3 parts of Flos Rosae Rugosaes, this medicine also comprises 35 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites, and this medicine can effectively be treated leukodermic symptom, has no side effect.
The present invention is that one is treated leukodermic Chinese medicine, and described Chinese medicine comprises the medicine of following weight portion: 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Scutellariaes, 60 parts of Fructus Psoraleaes, 20 parts, Semen sojae atricolor, 20 parts of Fructus Jujubaes, 20 parts of Radix Curcumaes, 10 parts, Flos Carthami, 10 parts, Semen Persicae, 15 parts of Cordyceps, 5 parts of Flos Rosae Rugosaes, this medicine also comprises 40 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites, and this medicine can effectively be treated leukodermic symptom, has no side effect.
Radix Angelicae Sinensis sweet in the mouth, warm in nature, the effect that having enriches blood invigorates blood circulation, Radix Angelicae Sinensis can also regulate the immunologic function of body simultaneously, has benefiting vital QI and blood, tonification liver, and treatment vitiligo is had to good effect; Radix Scutellariae bitter in the mouth, has effect of removing toxic substances, can liver and kidney tonifying; Fructus Psoraleae has effect of reinforcing the kidney and supporting YANG, helping inspiration to relieve asthma, main insufficiency of kidney-YANG, and failure of the kidney in receiving QI, asthenia of both the spleen and kidney is mainly used for treating vitiligo; Nutritious black bean is abundant, has various bioactivators, and as studies on black soybean pigment, Semen sojae atricolor polysaccharide and isoflavone etc., especially studies on black soybean pigment is a kind of active components of plants with important medical value, and treatment vitiligo is had to good curative effect; Fructus Jujubae can drive qi-blood circulating, reduces cardiovascular silting up; Radix Curcumae major function is promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, and the removing heat from blood that clears away heart-fire, regulates vim and vigour; Semen Persicae bitter but sweet flavor and property are flat, availablely control the various worn-out diseases of stagnation of blood stasis; Flos Carthami has effect of promoting blood flow to regulate menstruation, eliminating stasis to stop pain; Cordyceps contains cordycepin, aminoacid, polysaccharide, protein etc., is that nutritional labeling is very abundant, meanwhile, also finds that Cordyceps has effect of liver and kidney tonifying, tonifying the lung spleen invigorating, can effectively improve the function of human body; Flos Rosae Rugosae sweet in the mouth, micro-hardship, temperature, main effect is circulation of qi promoting, has resolving depression, and blood, effect of pain relieving.
Poly phenolic acid of Radix Salviae Miltiorrhizae sterilization, activating blood circulation to dissipate blood stasis, improve microcirculation, remove the effect such as free radical, poly phenolic acid of Radix Salviae Miltiorrhizae and Semen Persicae, Flos Carthami all can play the effect of mutually promoting, and can effectively improve the situation of patients with vitiligo.
The present invention treats the Radix Angelicae Sinensis, Radix Scutellariae and the Fructus Psoraleae that in the medicine of leukodermic Chinese medicine, contain is all of value to benefiting vital QI and blood, liver and kidney tonifying, Semen sojae atricolor and Fructus Jujubae energy promoting flow of QI and blood, the other drugs such as Radix Curcumae Flos Carthami are energy dispelling wind and removing obstruction in the collateral, promoting flow of QI and blood all, are all the leukodermic optimal drugs for the treatment of, this important component is low, is applicable to level of mass consumption, the various effective ingredient that contain in medicine can be absorbed by the body, be conducive to strengthen human body constitution, therapeutic effect is high, has no side effect.
Claims (4)
1.
oneplant the leukodermic Chinese medicine for the treatment of, described Chinese medicine comprises the medicine of following weight portion: Radix Angelicae Sinensis 20-30 part, Radix Scutellariae 20-30 part, Fructus Psoraleae 50-60 part, Semen sojae atricolor 10-20 part, Fructus Jujubae 10-20 part, Radix Curcumae 10-20 part, Flos Carthami 6-10 part, Semen Persicae 6-10 part, Cordyceps 5-15 part, Flos Rosae Rugosae 1-5 part, this medicine also comprises poly phenolic acid of Radix Salviae Miltiorrhizae effective site 30-40 part.
2. one is treated leukodermic Chinese medicine according to claim 1, it is characterized in that: described Chinese medicine comprises the medicine of following weight portion: 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Scutellariaes, 50 parts of Fructus Psoraleaes, 10 parts, Semen sojae atricolor, 10 parts of Fructus Jujubaes, 10 parts of Radix Curcumaes, 6 parts, Flos Carthami, 6 parts, Semen Persicae, 5 parts of Cordyceps, 1 part of Flos Rosae Rugosae, this medicine also comprises 30 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
3. one is treated leukodermic Chinese medicine according to claim 1, it is characterized in that: described Chinese medicine comprises the medicine of following weight portion: 25 parts of Radix Angelicae Sinensis, 25 parts of Radix Scutellariaes, 55 parts of Fructus Psoraleaes, 15 parts, Semen sojae atricolor, 15 parts of Fructus Jujubaes, 15 parts of Radix Curcumaes, 8 parts, Flos Carthami, 8 parts, Semen Persicae, 10 parts of Cordyceps, 3 parts of Flos Rosae Rugosaes, this medicine also comprises 35 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
4. one is treated leukodermic Chinese medicine according to claim 1, it is characterized in that: described Chinese medicine comprises the medicine of following weight portion: 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Scutellariaes, 60 parts of Fructus Psoraleaes, 20 parts, Semen sojae atricolor, 20 parts of Fructus Jujubaes, 20 parts of Radix Curcumaes, 10 parts, Flos Carthami, 10 parts, Semen Persicae, 15 parts of Cordyceps, 5 parts of Flos Rosae Rugosaes, this medicine also comprises 40 parts of poly phenolic acid of Radix Salviae Miltiorrhizae effective sites.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492582.0A CN103830659A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492582.0A CN103830659A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating leucoderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103830659A true CN103830659A (en) | 2014-06-04 |
Family
ID=50794761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210492582.0A Pending CN103830659A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103830659A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101528448B1 (en) * | 2015-01-05 | 2015-06-11 | 을지대학교 산학협력단 | A composition for improving skin conditions containing salvianolic acid B |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322788A (en) * | 2008-08-07 | 2008-12-17 | 张宗保 | Traditional Chinese medicine for treating vitiligo and preparation method thereof |
| CN101637512A (en) * | 2009-09-11 | 2010-02-03 | 刁保忠 | Traditional Chinese medicine preparation for treating vitiligo |
-
2012
- 2012-11-28 CN CN201210492582.0A patent/CN103830659A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322788A (en) * | 2008-08-07 | 2008-12-17 | 张宗保 | Traditional Chinese medicine for treating vitiligo and preparation method thereof |
| CN101637512A (en) * | 2009-09-11 | 2010-02-03 | 刁保忠 | Traditional Chinese medicine preparation for treating vitiligo |
Non-Patent Citations (4)
| Title |
|---|
| 刘璋等: "黑素生成过程中黄芩的调节作用", 《武汉大学学报(医学版)》 * |
| 李士华 赵燕主编: "《白癜风患者的家庭养护》", 30 April 2008, 科学技术文献出版社 * |
| 查日煌等: "中医药治疗白癜风的新进展", 《甘肃中医》 * |
| 罗和骨等主编: "《经方验方巧治皮肤病 下册》", 30 September 2007, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101528448B1 (en) * | 2015-01-05 | 2015-06-11 | 을지대학교 산학협력단 | A composition for improving skin conditions containing salvianolic acid B |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101322789A (en) | Medicinal liquor prescription for treating rheumatism and rheumatoid | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN103212040B (en) | Chinese medicinal composition for treatment of seborrheic alopecia | |
| CN104721425A (en) | Traditional Chinese medicine foot bath powder for improving sleep, and preparation and use methods thereof | |
| CN104667047A (en) | Traditional Chinese medicine liquor for treating diabetic feet | |
| CN104560567A (en) | Medicated wine for treating lingering arthralgia and weakened body resistance and application thereof | |
| CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
| CN105362990A (en) | Beverage for improving iciness of disease | |
| CN105233218A (en) | Traditional Chinese medicinal composition for treating deficiency-cold in spleen and stomach and intestine asthenic diarrhea | |
| CN102247552A (en) | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases | |
| CN103239656B (en) | Traditional Chinese medicine for treating psoriasis | |
| CN104758845A (en) | External traditional Chinese medicine ointment for treating scapulohumeral periarthritis | |
| CN103830659A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN103800799A (en) | Traditional Chinese medicine for treating stomach cancer | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN107349413A (en) | A kind of bubble pin formula using ginger as raw material | |
| CN102380041B (en) | Traditional Chinese herbal lotion preparation method for curing night sweat decubitus | |
| CN102451458A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN106491776A (en) | A kind of Chinese lavipeditum composition for treating hygropyretic beriberi | |
| CN103784621A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis and preparation method thereof | |
| CN102579718A (en) | Chinese medicament for treating kidney qi deficiency type prostatitis | |
| CN104069421A (en) | Traditional Chinese medicine composition for treating heart diseases | |
| CN102526685A (en) | Medicament for treating cervical spondylosis | |
| CN1219047C (en) | Sanyu health wine | |
| CN103656033A (en) | Compound medicine for treating costal chondritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140604 |
|
| RJ01 | Rejection of invention patent application after publication |